These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1682 related articles for article (PubMed ID: 8599466)

  • 21. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
    Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
    J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p-27 (kip1) in nevi and melanomas.
    Morgan MB; Cowper SE
    Am J Dermatopathol; 1999 Apr; 21(2):121-4. PubMed ID: 10218670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of the maturation parameter by using computer-assisted interactive image analysis may be helpful in the differential diagnosis between compound Spitz nevus and malignant melanoma.
    Bergman R; Sabo E; Schafer I
    Am J Dermatopathol; 1996 Dec; 18(6):567-70. PubMed ID: 8989927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 gene mutation and expression in naevi and melanomas.
    Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
    Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silhouette symmetry: an unsupportable histologic criterion for distinguishing Spitz nevi and compound nevi from malignant melanoma.
    Okun MR
    Arch Pathol Lab Med; 1997 Jan; 121(1):48-53. PubMed ID: 9111092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The melanocyte differentiation pathway in spitz nevi.
    Cramer SF
    Am J Dermatopathol; 1998 Dec; 20(6):555-70. PubMed ID: 9855351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus.
    Wong TY; Suster S; Duncan LM; Mihm MC
    Hum Pathol; 1995 Feb; 26(2):171-9. PubMed ID: 7860047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
    de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
    Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid synthase expression in cutaneous melanocytic neoplasms.
    Kapur P; Rakheja D; Roy LC; Hoang MP
    Mod Pathol; 2005 Aug; 18(8):1107-12. PubMed ID: 15920554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.